You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 456 Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab

Article info

Article menu

Download PDFPDF

Poster
IGCS20_1497
456 Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab
Free

Authors

Citation

Wan Hua T, Chi-Huang H, Hui-Hua C, et al
456 Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab
International Journal of Gynecologic Cancer 2020;30:A189-A190.

Publication history

  • First published November 13, 2020.
Online issue publication 
November 13, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.